Clinical Trial Update: Effect of Olive Leaves as Hypoglycemic Agents in Diabetic Subjects [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating olive leaf extract as a hypoglycemic agent in people with diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Olive Leaf Extract (Olea europaea leaf extract)

Snippet

Sponsor: Wolfson Medical Center | Conditions: Diabetes | Phase 3 | Status: COMPLETED